Capricor Gets Complete Response For DMD Cell Therapy

Unconvincing Data Or A New Attitude At FDA?

 
• By Joseph Haas
  
DMD
Capricor hopes an ongoing Phase III study will provide data needed to resolve a CRL • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies